This compound is a pharmaceutical intermediate impurity reference standard, specifically a stereochemically defined pyrazine derivative with ether and aromatic ring substituents. It is primarily used as a reference material in pharmaceutical manufacturing and quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1429560-52-0
(3R,5R,8R,9R,10S,13S,14S,17E)-17-ethylidene-3,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-ol
pharmaceutical intermediate
2-Bromo-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone
pharmaceutical intermediate
2-((6-Chloro-3-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
pharmaceutical intermediate
2-[[6-[(3R)-3-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile
pharmaceutical intermediate
(5R)-4-[(2,4-dimethoxyphenyl)methyl]-6-ethoxy-5-methyl-3,5-dihydro-2H-pyrazine
WVNRXYGQXBXMGC-GFCCVEGCSA-N
CCOC1=NCCN([C@@H]1C)CC2=C(C=C(C=C2)OC)OC